特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
935832

バイオ医薬品受託製造市場レポート 2020-2030年:プロセス開発・充填 & 最終製品化・分析&品質管理研究・パッケージングおよび主要企業の分析

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030: Forecasts by Service (Process Development, Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product, plus Analysis of Leading Companies

出版日: | 発行: Visiongain Ltd | ページ情報: 英文 179 Pages | 納期: 即日から翌営業日

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=140.11円

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

バイオ医薬品受託製造市場レポート 2020-2030年:プロセス開発・充填 & 最終製品化・分析&品質管理研究・パッケージングおよび主要企業の分析
出版日: 2020年03月04日
発行: Visiongain Ltd
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオ医薬品受託製造市場では、CDMO / CMOによるバイオ医薬品製造能力の継続的な拡大が見られます。同市場では、最終製品化サービス需要が増加しています。バイオ医薬品製造の新たな地域としてアジアが台頭しています。しかし、熟練労働者の不足、高額な製造設備の要件と複雑なプロセスが参入障壁を高めており、市場成長を抑制しています。複雑かつ厳格な規制要件も市場成長を妨げています。

当レポートでは、世界のバイオ医薬品受託製造市場について調査分析し、サービス・製品別の各セグメントおよび地域別によるの市場分析と予測、市場発展への影響要因、競合環境、および主要企業などについて、体系的な情報を提供しています。

第1章 レポートの概要

第2章 バイオ医薬品受託製造:エグゼクティブサマリー

第3章 バイオ医薬品契約製造市場のイントロダクション

  • バイオ医薬品受託製造とは?
  • バイオ医薬品の受託製造におけるサービスの種類
    • プロセス開発
    • 充填および最終製品化
    • 分析および品質管理研究
    • パッケージング
  • バイオ医薬品受託製造における製品の種類
    • 生物製剤
    • バイオシミラー
  • バイオ医薬品受託製造市場に影響を与える要因

第4章 バイオ医薬品契約製造市場の展望

  • バイオ医薬品の製造委託産業の動向
    • CDMO / CMOによるバイオ医薬品製造能力の継続的な拡大
    • バイオ医薬品関連の製造活動のアウトソーシングの増加
    • バイオ医薬品受託製造市場での最終製品化サービスの需要の増加
    • バイオ医薬品製造プロセスの生産性と効率の向上
    • バイオ医薬品製造業界によるシングルユース製造システムの採用
    • バイオ医薬品製造の新たな地域として浮上しているアジア
  • 市場の推進要因と抑制要因
    • 市場成長要因
    • 市場抑制要因
  • バイオ医薬品受託製造の将来の機会
    • バイオ医薬品を含む多数の研究
    • 以前は治療できなかった疾患を治療するためのバイオ医薬品の可能性
    • バイオ医薬品に焦点を合わせた企業の高額な研究開発費
  • PESTEL分析
  • バイオ医薬品の商業的成功とその結果としてのバイオ医薬品の需要の増加
  • 生物製剤の成長
  • バイオ医薬品パイプライン
  • 確立されたバイオ医薬品メーカー間でアウトソーシングは限定的
  • シングルユースのバイオプロセッシング装置およびソリューションの登場
  • バイオシミラー薬剤のパイプライン分析

第5章 バイオ医薬品受託製造市場:サービス別

  • バイオ医薬品受託製造市場の展望:サービス別
  • プロセス開発収益予測
  • フィルアンドフィニッシュ (充填&最終製品化) オペレーションの収益予測
  • 分析および品質管理研究の収益予測
  • パッケージングの収益予測

第6章 バイオ医薬品受託製造市場:製品別

  • バイオ医薬品受託製造市場の展望:製品別
  • 生物製剤の収益予測
  • モノクローナル抗体の収益予測
  • 組換えタンパク質の収益予測
  • ワクチンの収益予測
  • インスリンの収益予測
  • バイオシミラーの収益予測

第7章 バイオ医薬品受託製造市場:原料別

  • バイオ医薬品受託製造市場の展望:原料別
  • 哺乳類細胞培養の収益予測
  • 微生物の収益予測

第8章 バイオ医薬品受託製造市場:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東&アフリカ
    • GCC
    • 南アフリカ0
    • その他中東&アフリカ

第9章 バイオ医薬品受託製造の主要企業

  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies
  • 東洋紡株式会社
  • WuXi Biologics
  • Thermo Fisher Scientific Inc.
  • JRS PHARMA
  • Inno Bio Ventures
  • AGC Biologics
  • AbbVie、Inc.
  • Binex Co.、Ltd.
  • Samsung BioLogics
  • ProBioGen
  • Rentschler Biotechnologie GmbH
  • Lonza
  • Sandoz

第10章 SWOT分析

第11章 結論と推奨事項

第12章 用語集

第13章 付録

図表

List of Figures

  • FIG.1 Process Development in Biopharmaceuticals Contract Manufacturing Industry
  • FIG.2 Fill & Finish Operations in Biopharmaceuticals Contract Manufacturing Industry
  • FIG.3 Estimated Average Activity Outsourced (% respondents, 2019)
  • FIG.4 Approximate Biopharmaceuticals Processing Facilities - by Countries (2019)
  • FIG.5 Outsourcing to CDMOs - by Types of Products (2019)
  • FIG.6 Outsourcing manufacturing of Newly Approved Drug - by size of biotech companies (%, 2019)
  • FIG.7 Global Top 10 Selling Drugs ($ billon, 2018)
  • FIG.8 R&D spend as a Percent of Total Sales (2019)
  • FIG.9 Global Biopharmaceutical Market ($ billion, 2016-2024)
  • FIG.10 Regional Split of Biopharmaceutical Adoption (2019)
  • FIG.11 Biologics vs. Biosimilars Approvals by US FDA
  • FIG.12 Number of Biologics Approved by US FDA (1960-2019)
  • FIG.13 Share of Pharmaceutical and Biopharmaceuticals in U.S. (2019)
  • FIG.14 Share of Pharmaceutical and Biopharmaceuticals Japan (2019)
  • FIG.15 Share of Pharmaceutical and Biopharmaceuticals Europe (2019)
  • FIG.16 Share of Pharmaceutical and Biopharmaceuticals China (2019)
  • FIG.17 Global Biopharmaceuticals Contract Manufacturing Market Size By Service, 2020 - 2030 (USD Mn)
  • FIG.18 Global Biopharmaceuticals Contract Manufacturing Market Share By Service, 2020, 2025, 2030 (%)
  • FIG.19 Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.20 Downstream Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.21 Upstream Process Development for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.22 Fill & Finish Operations for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.23 Analytical & Quality Control Studies for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.24 Packaging for Biopharmaceuticals Contract Manufacturing Market, 2020 - 2030 (USD Mn, AGR %)
  • FIG.25 Global Biopharmaceuticals Contract Manufacturing Market Size By Product, 2020 - 2030 (USD Mn)
  • FIG.26 Global Biopharmaceuticals Contract Manufacturing Market Share By Product, 2020, 2025, 2030 (%)
  • FIG.27 Biopharmaceuticals Contract Manufacturing Market for Biologics, 2020 - 2030 (USD Mn, AGR %)
  • FIG.28 Biopharmaceuticals Contract Manufacturing Market for Monoclonal Antibodies, 2020 - 2030 (USD Mn, AGR %)
  • FIG.29 Biopharmaceuticals Contract Manufacturing Market for Recombinant Proteins, 2020 - 2030 (USD Mn, AGR %)
  • FIG.30 Biopharmaceuticals Contract Manufacturing Market for Vaccines, 2020 - 2030 (USD Mn, AGR %)
  • FIG.31 Biopharmaceuticals Contract Manufacturing Market for Insulin, 2020 - 2030 (USD Mn, AGR %)
  • FIG.32 Biopharmaceuticals Contract Manufacturing Market for Biosimilars, 2020 - 2030 (USD Mn, AGR %)
  • FIG.33 Global Biopharmaceuticals Contract Manufacturing Market Size By Source, 2020 - 2030 (USD Mn)
  • FIG.34 Global Biopharmaceuticals Contract Manufacturing Market Share By Source, 2020, 2025, 2030 (%)
  • FIG.35 Biopharmaceuticals Contract Manufacturing Market for Mammalian, 2020 - 2030 (USD Mn, AGR %)
  • FIG.36 Biopharmaceuticals Contract Manufacturing Market for Microbial, 2020 - 2030 (USD Mn, AGR %)
  • FIG.37 Global Biopharmaceuticals Contract Manufacturing Market Size By Region, 2020 - 2030 (USD Mn)
  • FIG.38 Global Biopharmaceuticals Contract Manufacturing Market Share By Region, 2020, 2025, 2030 (%)
  • FIG.39 North America Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.40 North America Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.41 U.S. Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.42 Canada Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.43 Europe Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.44 Europe Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.45 Total pharmaceutical market sales forecast in Europe from 2012 to 2022 (Billion Euros)
  • FIG.46 Germany Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.47 France Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.48 UK Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.49 Russia Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.50 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.53 China Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.54 Japan Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.55 India Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.56 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.57 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.58 Latin America Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.59 Latin America Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.60 Brazil Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.61 Argentina Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.62 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.63 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.64 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.65 GCC Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.66 South Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.67 Rest of Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size, 2020 - 2030 (USD Mn, %)
  • FIG.68 Boehringer Ingelheim International GmbH: Financials (2016 - 2018)
  • FIG.69 Boehringer Ingelheim International GmbH: Sales by Region (2018, %)
  • FIG.70 Boehringer Ingelheim International GmbH: Sales by Product (2018, %)
  • FIG.71 TOYOBO CO., LTD.: Sales by Business Segment (2019, %)
  • FIG.72 TOYOBO CO., LTD.: Sales by Region (2019, %)
  • FIG.73 TOYOBO CO., LTD.: Healthcare Segment Sales (2012 - 2019, $ million)
  • FIG.74 WuXi Biologics: Sales and Net Profit Margin, 2017 - 2019 ($ million, %)
  • FIG.75 WuXi Biologics: Sales by Region, 2019 (%)
  • FIG.76 Thermo Fisher Scientific Inc.: Sales by Segment, 2019 (%)

List of Tables

  • Table 1 List of Novel Biologics Approved By US FDA In The Year 2019 And Their Projected Sales
  • Table 2 Various Biosimilars Samsung Bioepis Is Developing
  • Table 3 Process Development for Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 4 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Downstream 2020 2030 (USD Mn, AGR %, CAGR%)
  • Table 5 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Upstream 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 6 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Fill & Finish Operations 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 7 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Analytical & Quality Control Studies 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 8 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Packaging 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 9 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Biologics 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 10 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Monoclonal Antibodies 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 11 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Recombinant Proteins 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 12 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Vaccines 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 13 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Insulin 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 14 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Biosimilars 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 15 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Mammalian 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 16 Biopharmaceuticals Contract Manufacturing Market Value Forecast for Microbial 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 17 North America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 18 U.S. Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 19 Canada Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 20 Europe Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 21 Germany Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020 2030 (USD Mn, AGR %, CAGR%)
  • Table 22 France Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 23 UK Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 24 Russia Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 25 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 26 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 27 China Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 28 Japan Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 29 India Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 30 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 31 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 32 Latin America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020- 2030 (USD Mn, AGR %, CAGR%)
  • Table 33 Brazil Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 34 Argentina Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 35 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 36 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 37 GCC Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 38 South Africa Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 39 Rest of Middle East Biopharmaceuticals Contract Manufacturing Market Value Forecast 2020-2030 (USD Mn, AGR %, CAGR%)
  • Table 40 Boehringer Ingelheim International GmbH: Product Benchmarking
  • Table 41 Boehringer Ingelheim International GmbH: Financial Performance (2018)
  • Table 42 FUJIFILM Diosynth Biotechnologies: Product Benchmarking
  • Table 43 TOYOBO CO., LTD.: Product Benchmarking
  • Table 44 TOYOBO CO., LTD.: Financial Performance (2017 - 2019)
  • Table 45 WuXi Biologics: Product Benchmarking
  • Table 46 WuXi Biologics: Financial Performance (2017 - 2019)
  • Table 47 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 48 Thermo Fisher Scientific Inc.: Financial Performance (2017 - 2019)
  • Table 49 JRS PHARMA: Product Benchmarking
  • Table 50 Inno Bio Ventures: Product Benchmarking
  • Table 51 Inno Bio Ventures: Financial Performance (2019)
  • Table 52 AGC Biologics: Product Benchmarking
  • Table 53 AGC Biologics: Financial Performance (2018)
  • Table 54 AbbVie, Inc.: Product Benchmarking
  • Table 55 AbbVie, Inc.: Financial Performance (2018)
  • Table 56 Binex Co., Ltd.: Product Benchmarking
  • Table 57 Binex Co., Ltd.: Financial Performance (2017 - 2019)
  • Table 58 Samsung BioLogics: Product Benchmarking
  • Table 59 Samsung BioLogics: Financial Performance (2017 - 2019)
  • Table 60 ProBioGen: Product Benchmarking
  • Table 61 ProBioGen: Financial Performance (2018)
  • Table 62 Rentschler Biotechnologie GmbH: Product Benchmarking
  • Table 63 Rentschler Biotechnologie GmbH: Financial Performance (2018)
  • Table 64 Lonza: Product Benchmarking
  • Table 65 Lonza: Financial Performance (2017 - 2019)
  • Table 66 Sandoz: Product Benchmarking
  • Table 67 Sandoz: Financial Performance (2017 - 2019)
目次
Product Code: PHA0629

Market Dynamics

  • Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
  • Increasing outsourcing of biopharmaceuticals-related manufacturing activities
  • Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
  • Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
  • Uptake of single-use production systems by the biopharmaceutical manufacturing industry
  • Asia emerging as hot destination for biopharmaceutical manufacturing
  • Increasing confidence of pharmaceutical industry in CDMOs capabilities
  • High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
  • Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
  • Increasing shortage of skilled workforce in the biopharmaceutical industry
  • Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
  • Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030

Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

Process Development

  • Downstream
  • Upstream

Fill & Finish Operations

Analytical & Quality Control Studies

Packaging

Product

Biologics

  • Monoclonal Antibodies (MAbs)
  • Recombinant Proteins
  • Vaccines
  • Insulin

Biosimilars

Regional Breakdown

Focused regional forecasts and analysis explore the future opportunities:

North America

  • U.S.
  • Canada

Europe

  • UK
  • France
  • Germany
  • Russia
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East

Buy our report today Biopharmaceuticals Contract Manufacturing Market Report 2020-2030: Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies . Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Biopharmaceuticals Contract Manufacturing Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered By This Analytical Report
  • 1.5. Who Is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation & Forecasting Methodology
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Associated Visiongain Reports
  • 1.9. About Visiongain

2. Biopharmaceutical Contract Manufacturing: Executive Summary

3. Introduction to the Biopharmaceuticals Contract Manufacturing Market

  • 3.1. What is Biopharmaceutical Contract Manufacturing?
  • 3.2. Types of Services in Biopharmaceuticals Contract Manufacturing
    • 3.2.1. Process Development
    • 3.2.2. Fill & Finish Operations
    • 3.2.3. Analytical & Quality Control Studies
    • 3.2.4. Packaging
  • 3.3. Types of Products in Biopharmaceuticals Contract Manufacturing
    • 3.3.1. Biologics
    • 3.3.2. Biosimilar
  • 3.4. Factors Impacting Biopharmaceuticals Contract Manufacturing Market

4. Biopharmaceuticals Contract Manufacturing Market Outlook

  • 4.1. Trends in Biopharmaceuticals Contract Manufacturing Industry
    • 4.1.1. Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
    • 4.1.2. Increasing outsourcing of biopharmaceuticals-related manufacturing activities
    • 4.1.3. Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
    • 4.1.4. Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
    • 4.1.5. Uptake of single-use production systems by the biopharmaceutical manufacturing industry
    • 4.1.6. Asia emerging as hot destination for biopharmaceutical manufacturing
  • 4.2. Market Drivers and Restraints
    • 4.2.1. Market Drivers
      • 4.2.1.1. Increasing confidence of pharmaceutical industry in CDMOs capabilities
      • 4.2.1.2. High level of outsourcing of newly approved drugs by smaller biotech companies to boost the growth
      • 4.2.1.3. Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
    • 4.2.2. Market Restraints
      • 4.2.2.1. Increasing shortage of skilled workforce in the biopharmaceutical industry
      • 4.2.2.2. Expensive and complex manufacturing equipment requirements pose as entry barriers
      • 4.2.2.3. Complicated and stringent regulatory requirements hinder market growth
      • 4.2.2.4. Transfer complexity
  • 4.3. Biopharmaceuticals Contract Manufacturing future opportunities
    • 4.3.1. High number studies involving biopharmaceuticals
    • 4.3.2. Potential of biopharmaceuticals to treat previously untreatable diseases
    • 4.3.3. High R&D spend of Biopharmaceutical-focused companies
  • 4.4. PESTEL Analysis
  • 4.5. The commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
  • 4.6. Growth of biologics
  • 4.7. Biopharmaceuticals pipeline
  • 4.8. Limited outsourcing amongst well-established biopharmaceutical manufacturer
  • 4.9. The Emergence of single-use bioprocessing equipment & solutions
  • 4.10. Pipeline analysis for Biosimilar drugs

5. Biopharmaceuticals Contract Manufacturing Market By Service

  • 5.1. Biopharmaceuticals Contract Manufacturing Market Outlook By Service
  • 5.2. Process Development Revenue Forecast
    • 5.2.1. Downstream Revenue Forecast
    • 5.2.2. Upstream Revenue Forecast
  • 5.3. Fill & Finish Operations Revenue Forecast
  • 5.4. Analytical & Quality Control Studies Revenue Forecast
  • 5.5. Packaging Revenue Forecast

6. Biopharmaceuticals Contract Manufacturing Market By Product

  • 6.1. Biopharmaceuticals Contract Manufacturing Market Outlook By Product
  • 6.2. Biologics Revenue Forecast
  • 6.3. Monoclonal Antibodies Revenue Forecast
  • 6.4. Recombinant Proteins Revenue Forecast
  • 6.5. Vaccines Revenue Forecast
  • 6.6. Insulin Revenue Forecast
  • 6.7. Biosimilars Revenue Forecast

7. Biopharmaceuticals Contract Manufacturing Market by Source

  • 7.1. Biopharmaceuticals Contract Manufacturing Market Outlook by Source
  • 7.2. Mammalian Cell Culture Revenue Forecast
  • 7.3. Microbial Revenue Forecast

8. Biopharmaceuticals Contract Manufacturing Market By Region

  • 8.1. North America Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.1.1. U.S. Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.1.2. Canada Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
  • 8.2. Europe Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.2.1. Germany Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.2.2. France Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.2.3. UK Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.2.4. Russia Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.2.5. Rest of Europe Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
  • 8.3. Asia Pacific Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.3.1. China Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.3.2. Japan Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.3.3. India Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.3.4. Southeast Asia Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.3.5. Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
  • 8.4. Latin America Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.4.1. Brazil Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.4.2. Argentina Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.4.3. Rest of Latin America Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
  • 8.5. Middle East & Africa Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.5.1. GCC Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.5.2. South Africa Biopharmaceuticals Contract Manufacturing Market 2020 - 2030
    • 8.5.3. Rest of Middle East & Africa Biopharmaceuticals Contract Manufacturing Market 2020 - 2030

9. The Leading Biopharmaceuticals Contract Manufacturing Companies

  • 9.1. Boehringer Ingelheim International GmbH
    • 9.1.1. Company Overview
    • 9.1.2. Product Benchmarking
    • 9.1.3. Financials
    • 9.1.4. Recent News
  • 9.2. FUJIFILM Diosynth Biotechnologies
    • 9.2.1. Company Overview
    • 9.2.2. Product Benchmarking
    • 9.2.3. Financials
    • 9.2.4. Recent News
  • 9.3. TOYOBO CO., LTD.
    • 9.3.1. Company Overview
    • 9.3.2. Product Benchmarking
    • 9.3.3. Financials
    • 9.3.4. Recent News
  • 9.4. WuXi Biologics
    • 9.4.1. Company Overview
    • 9.4.2. Product Benchmarking
    • 9.4.3. Financials
    • 9.4.4. Recent News
  • 9.5. Thermo Fisher Scientific Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Product Benchmarking
    • 9.5.3. Financials
    • 9.5.4. Recent News
  • 9.6. JRS PHARMA
    • 9.6.1. Company Overview
    • 9.6.2. Product Benchmarking
    • 9.6.3. Recent News
  • 9.7. Inno Bio Ventures
    • 9.7.1. Company Overview
    • 9.7.2. Product Benchmarking
    • 9.7.3. Financials
  • 9.8. AGC Biologics
    • 9.8.1. Company Overview
    • 9.8.2. Product Benchmarking
    • 9.8.3. Financials
    • 9.8.4. Recent News
  • 9.9. AbbVie, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Product Benchmarking
    • 9.9.3. Financials
    • 9.9.4. Recent News
  • 9.10. Binex Co., Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Product Benchmarking
    • 9.10.3. Financials
    • 9.10.4. Recent News
  • 9.11. Samsung BioLogics
    • 9.11.1. Company Overview
    • 9.11.2. Product Benchmarking
    • 9.11.3. Financials
    • 9.11.4. Recent News
  • 9.12. ProBioGen
    • 9.12.1. Company Overview
    • 9.12.2. Product Benchmarking
    • 9.12.3. Financials
    • 9.12.4. Recent News
  • 9.13. Rentschler Biotechnologie GmbH
    • 9.13.1. Company Overview
    • 9.13.2. Product Benchmarking
    • 9.13.3. Financials
    • 9.13.4. Recent News
  • 9.14. Lonza
    • 9.14.1. Company Overview
    • 9.14.2. Product Benchmarking
    • 9.14.3. Financials
    • 9.14.4. Recent News
  • 9.15. Sandoz
    • 9.15.1. Company Overview
    • 9.15.2. Product Benchmarking
    • 9.15.3. Financials
    • 9.15.4. Recent News

10. SWOT Analysis

  • 10.1. Strength
  • 10.2. Weakness
  • 10.3. Opportunities
  • 10.4. Threats

11. Conclusion & Recommendations

12. Glossary

  • Visiongain Report Sales Order Form
  • Appendix A
    • About Visiongain

13. Appendix

  • 13.1. Visiongain report evaluation form
  • Order Form
  • Appendix A
    • About Visiongain
  • Appendix B
    • Visiongain report evaluation form
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.